Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 416Lymphoma 406Lymphoma, Non-Hodgkin 344Leukemia, Lymphocytic, Chronic, B-Cell 313Lymphoma, Follicular 301Lymphoma, Mantle-Cell 226Lymphoma, B-Cell, Marginal Zone 161Lymphoma, B-Cell 112Leukemia 112Burkitt Lymphoma 110Waldenstrom Macroglobulinemia 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Recurrence 82Hodgkin Disease 60Lymphoma, Large-Cell, Immunoblastic 57Neoplasms 33Lymphoma, Large-Cell, Anaplastic 26Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 24Multiple Myeloma 21Dendritic Cell Sarcoma, Interdigitating 19Intraocular Lymphoma 17Leukemia, Prolymphocytic 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, T-Cell 14Hematologic Neoplasms 13Lymphoproliferative Disorders 12Leukemia, Hairy Cell 11Leukemia, B-Cell 11Hematologic Diseases 11

Interventions

Doxorubicin 6Vincristine 4Dexrazoxane 4Razoxane 3Radiotherapy 2Prednisone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Exercise 2Etoposide 2Cyclophosphamide 2Bleomycin 2pegfilgrastim 1hydrocortisone hemisuccinate 1Vascular Stiffness 1VAP-cyclo protocol 1Secondary Prevention 1Rituximab 1Pulse Wave Analysis 1Prednisolone 1Nebivolol 1Methotrexate 1Methods 1Mercaptopurine 1Leucovorin 1Lenalidomide 1Hydrocortisone 1Electrocardiography 1Echocardiography 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Rituximab × Lymphoid × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡